Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Parmax Pharma Share Price
137.75-1.35 (-0.97%)
+333.18% past 1 Year
News
European Stock Futures Decline Across Major Regional Benchmarks
Broader Market
Indian Companies Scheduled To Announce Quarterly Earnings On October 15
Equity
HDB Financial gains while IDBI Bank sale reshapes banking sector outlook
Equity
HDB Financial Services Reports Strong Profit Growth Despite Asset Quality Deterioration
Equity
Tata Technologies Reports Strong Revenue Growth Despite Profit Estimate Miss
Equity
Government Approves Fairfax Acquisition Of Majority Stake In IDBI Bank
Equity
Enviro Infra Subsidiary Secures Rs 228 Crore Wind Power EPC Order
Equity
Indian Phosphate Reports Strong Revenue Growth In Second Quarter FY27
Equity
Bajaj Consumer Care Reports Strong Q2 Profit And Margin Expansion
Equity
Om Power Transmission Receives Rs 102 Crore Contract Letter
Equity
Emmvee Reports Strong Q2 Profit Growth With Revenue and EBITDA Expansion
Equity
ICICI Lombard Reports Strong Q2 Profit Growth Above Analyst Expectations
Equity
Hathway Q2 Net Profit Falls Despite Revenue Growth, EBITDA Margin Contracts
Equity
USFDA Completes FTO 9 Inspection With Three Observations
Equity
MRPL Reports Strong Q2 Profit Growth Despite Sequential Revenue Decline
Equity
Asian Markets Decline Sharply Following Wall Street Technology Selloff
Broader Market
US Considers Easing Shadow Fleet Sanctions To Lower Freight Rates
Commodity
US Stock Futures Decline, Nasdaq Leads Losses Ahead Of Inflation Data
Broader Market
North Korea Reports Submarine Launched Cruise Missile Tests Raising Regional Tensions
Broader Market
Explosions Reported In Yemen Capital As Regional Tensions Escalate
Broader Market